Ibrutinib Impurity 11
Impurity
This molecule is a impurity of Ibrutinib.
In Stock
Impurity
Ibrutinib Impurity 11
Cat. No. ANTPRD7371Old No. ANT-IBT-009CAS 1288338-96-4In Stock
Technical Data
New Cat. No.ANTPRD7371
Old Cat. No.ANT-IBT-009
CAS1288338-96-4
Mol. FormulaC25H25ClN6O2
Mol. Weight476.96 g/mol
IUPAC1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one
SMILESC1C[C@H](CN(C1)C(=O)CCCl)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
InChIInChI=1S/C25H25ClN6O2/c26-13-12-21(33)31-14-4-5-18(15-31)32-25-22(24(27)28-16-29-25)23(30-32)17-8-10-20(11-9-17)34-19-6-2-1-3-7-19/h1-3,6-11,16,18H,4-5,12-15H2,(H2,27,28,29)/t18-/m1/s1
InChI KeyVJQOEGZWPHTCTQ-GOSISDBHSA-N
Description
Overview
Ibrutinib Impurity 11, Ibrutinib, 1288338-96-4, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one
Anant Labs is the renowned and Authentic Manufacturer and Supplier of Ibrutinib Impurity 11 in India.
At Anant, we have expertise in synthetic organic chemistry and pharmaceutical analysis and we provide cost effective and accurate custom research services to the industry.
Synonyms
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-chloropropan-1-one1288338-96-41-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-chloropropan-1-one? (Imatinib Impurity)(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one(R)-N-Desacryloyl N-3-Chloropropionyl Ibrutinib(R)-N-Desacryloyl N-3-Propionyl Ibrutinib; 1-Propanone, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-chloro- (ACI); 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-chloro-1-propanone (ACI); (R)-1-[3-[4-Amino-3-((R)-N-Desacryloyl N-3-Propionyl IbrutinibNA99JX9VTSSCHEMBL1613909
